Search Results

CSL Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.cslseqirus.com.au/expertise

CSL Seqirus supports Australian public health through manufacture of antivenoms and q fever solutions.

https://www.cslseqirus.com.au/expertise/antivenom-and-q-fever-vaccines

CSL Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.

https://www.cslseqirus.com.au/manufacturing/global-manufacturing-network

CSL Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.

https://www.cslseqirus.com.au/manufacturing/technologies

CSL Seqirus is working tirelessly to optimise our technology and implement transformational long-term approaches to influenza pandemic preparedness.

https://www.cslseqirus.com.au/r-and-d

Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.

https://www.cslseqirus.com.au/our-company/leadership

Understand our aim to develop the next generation of influenza vaccines and how we're working to unite product platforms across the globe.

https://www.cslseqirus.com.au/manufacturing/technical-development

CSL Seqirus is the largest fully integrated commercialisation partner in Australia and New Zealand. Learn more about our pharmaceutical partnership capabilities.

https://www.cslseqirus.com.au/expertise/in-licensing

CSL Seqirus supports Australian public health through manufacture of antivenoms and q fever solutions.

https://www.cslseqirus.com.au/expertise/antivenom-and-q-fever-vaccines/case-study-myanmar

CSL Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.

https://www.cslseqirus.com.au/our-company